Evidence map›Paper›PMID 34704007›Full record

ArticleMetabolism open2021

Prevalence of metabolic syndrome, its risk factors and associated lifestyles in Myanmar adult people: A community based cross-sectional study.

Su Su Maw

Abstract read
In one paragraph

Article in Metabolism open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Su Su MawCommunity Health Nursing Department, University of Nursing, Yangon, 11131, Myanmar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesMetabolic syndrome (MetS) is the constellation of cardio-metabolic risk factors, and it can illustrate the coming burden of cardiovascular diseases and diabetes mellitus. Myanmar faces larger pressure from cardio-metabolic diseases and there is no existing data to understand the magnitude of MetS in adult population. This study aimed to investigate the extent of existing people with MetS in the community and to know the related lifestyle factors to MetS.

methodsA community based cross-sectional study was performed in convenient sample of 302 Myanmar adult people. Prevalence of MetS and associated risk factors were identified by collecting sociodemographic information, anthropometric measurements, and blood investigation of glucose and lipid profiles. Logistic regression analysis was performed for developing statistical models to estimate the odd ratios (OR) and confidence intervals (CI).

resultsPrevalence of MetS is 29.1%, and there is no significant difference between male and female prevalence. Abdominal obesity is the highest component of MetS (OR: 28.37, CI: 12.41-64.85, p < 0.001) especially for female (OR: 44.52, CI: 17.19-115.31, p < 0.001), and hypertriglyceridemia (OR: 11.05, CI: 6.20-19.66, p < 0.001) is the commonest in male. Age is the constant risk for developing MetS (OR: 4.06, CI: 1.91-8.64, p < 0.001) whereas the practice of midday nap is the behavior related to increased occurrence of MetS (OR: 1.97, CI: 1.16-3.38, p < 0.05). Dietary pattern, smoking status, drinking alcoholic beverages and physical activity involvement do not impact on the development of MetS. Education, occupation, income and other sociodemographic factors do not produce significant effect on cardio-metabolic status. Obesity, diabetes, and hypertensive conditions of community residents are also explored.

conclusionsModifiable pathophysiological conditions such as abdominal obesity, and obesity play a vital role in preventing MetS before it occurs while unmodifiable risk factor such as getting older and female sex are not as much important as changeable lifestyle habits.

Indexed as

Adult peopleCross-sectional studyLifestylesMetabolic syndromePrevalenceRisk factors

Identifiers

PMID34704007
PMCPMC8524241

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.